Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
06/06/2002 | US20020068317 Generating deactivated protein; generate nucleotide sequence coding protein, express sequences and recover protein |
06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
06/06/2002 | US20020068301 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
06/06/2002 | US20020068276 Methods for selecting functional polypeptides |
06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
06/05/2002 | EP1211261A2 Stable polymerized hemoglobin blood-substitute |
06/05/2002 | EP1210449A1 Methods for the detection, analysis and isolation of nascent proteins |
06/05/2002 | EP1210373A2 Congener independent detection of microcystin and nodularin congeners |
06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
06/05/2002 | EP1141375A4 Metallopeptide combinatorial libraries and applications |
06/05/2002 | EP0904096A4 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
06/05/2002 | EP0804281B1 Apparatus and method for multiple synthesis of organic compounds on polymer support |
06/05/2002 | EP0746398B1 Antibody purification |
06/05/2002 | EP0736095B1 Human circulating cytokine cc-1 |
06/05/2002 | EP0656419B1 Method for highly purifying human serum albumin |
06/04/2002 | US6399750 IGG separation medium |
06/04/2002 | US6399357 Filtration |
06/04/2002 | US6399333 Process for producing erythropoietin containing no animal proteins |
06/04/2002 | US6399071 Removal of xenobodies from body fluid |
06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
06/04/2002 | CA2076593C Polypeptides and use thereof |
06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
05/30/2002 | WO2002042736A2 Chemical-library composition and method |
05/30/2002 | WO2002042449A2 Method for selecting peptide ligands |
05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
05/30/2002 | WO2002042321A2 Mixed fibrils |
05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
05/30/2002 | WO2001092557A3 Reaction block assembly for chemical synthesis |
05/30/2002 | WO2001011373A8 Difference detection methods using matched multiple dyes |
05/30/2002 | US20020065392 Methods for production of protein |
05/30/2002 | US20020065284 Dipeptide derivatives |
05/30/2002 | US20020064824 Generating preferential binding protein; obtain nucleotide sequences, replace preferential nucleotides, translate nucleotide sequences, recover preferential protein |
05/30/2002 | US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles |
05/30/2002 | US20020064770 Detecting preferential receptor associating protein; obtain library, incubate with receptor, detect bound receptor complex, isolate receptor associating protein |
05/30/2002 | CA2426939A1 Cystoskeleton-associated proteins |
05/29/2002 | EP1208909A2 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support |
05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
05/29/2002 | EP1207955A1 Method and device for performing operations at charged microlocations |
05/29/2002 | EP1207909A2 Method for coupling molecules |
05/29/2002 | DE10058319A1 Verfahren zur Selektion von Peptid-Liganden A method for the selection of peptide ligands |
05/29/2002 | CN1351505A Short-chain peptide dye conjagates used as contrast agents for optical diagnostics |
05/28/2002 | US6395532 Modified enzymes and their use for peptide synthesis |
05/28/2002 | US6395491 Coding and storing information on substrate; code biopolymer sequence, attach to substrate, recover information by replication of biopolymer sequence |
05/28/2002 | US6395474 Peptide nucleic acids |
05/28/2002 | US6395270 Activated protein C formulations |
05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
05/28/2002 | CA2104780C Lipid fractionation |
05/28/2002 | CA2089663C Improved tangential filtration process and apparatus |
05/28/2002 | CA2071651C A parenterally administrable drug having thrombolytic activity and containing protein c |
05/28/2002 | CA2054715C Process for the preparation of n-protected dialkyl(2s,3s)-3-ethylaspartates |
05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
05/24/2002 | CA2363820A1 Biomolecule microarray support, biomolecule microarray using the support, and method of fabricating the support |
05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
05/23/2002 | WO2002040541A2 Transporters and ion channels |
05/23/2002 | WO2002040508A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
05/23/2002 | WO2002040497A1 In vitro protein synthesis using glycolytic intermediates as an energy source |
05/23/2002 | WO2002002596A3 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
05/23/2002 | WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions |
05/23/2002 | WO2001068565A3 Chemoselective ligation by use of a phosphine |
05/23/2002 | US20020062155 Method for creating physiologically active compounds |
05/23/2002 | US20020061840 Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositions |
05/23/2002 | US20020061568 Method for activating denatured protein |
05/23/2002 | US20020061551 Nucleotide sequences coding a regulatory protein for use in the treatment of tumors, arteriosclerosis, autoimmune and diseases, blood disorders, asthma, arthritis and leukemia |
05/23/2002 | US20020061513 Isolation of preferential cellular components; obtain genetically engineered cells, express vector, detect polypeptides on support, recover polypeptides |
05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
05/23/2002 | CA2428693A1 In vitro protein synthesis using glycolytic intermediates as an energy source |
05/23/2002 | CA2427010A1 Transporters and ion channels |
05/22/2002 | EP1206494A1 Computational design methods for making molecular mimetics |
05/22/2002 | EP1206483A2 Automated protein purification in the multiwell format by vacuum filtration |
05/22/2002 | EP1206482A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
05/22/2002 | EP1206451A1 Cyclopropylindole derivatives |
05/22/2002 | EP0766826B1 Synthesis of combinatorial libraries |
05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
05/22/2002 | CN1350544A Chemical systhesis and use of soluble membrane protein receptor domains |
05/22/2002 | CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use |
05/21/2002 | US6391657 Removal of viruses from protein solutions by ultrafiltration |
05/21/2002 | US6391609 Generation solution containing blood proteins; extract mammalian tissue, separate coagulaton factors, recover purfied blood protein |
05/21/2002 | US6391581 DNA encoding interleukin-4 receptors |
05/21/2002 | US6391569 Method to detect Dirofilaria immitis infection |
05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
05/21/2002 | CA2082636C Process for the preparation of sulfonylpristinamycin iib |
05/21/2002 | CA2059909C Alkylation of azaglycine derivatives |
05/21/2002 | CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same |
05/16/2002 | WO2002038610A1 Process for the preparation of latent antithrombin iii |
05/16/2002 | WO2002038595A2 Crystals and structure of luxs |
05/16/2002 | WO2001092469A3 Phosphorylated polypeptides and uses related thereto |
05/16/2002 | WO2001088533A3 Lipid uptake assays |
05/16/2002 | WO2001034765A9 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
05/16/2002 | US20020058792 Method for solubilization and naturation of somatotropins |
05/16/2002 | US20020058788 Deblocking a fluorene methoxy carbonyl in sample; obtain sample, incubate with sulfur compound, recover deblocked compound |
05/16/2002 | US20020058786 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
05/16/2002 | US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein |
05/16/2002 | US20020058625 Method for purifying factor vWF-complex by means of cation exchange chromatography |
05/16/2002 | US20020058624 Powder containing physiologically active peptide |
05/16/2002 | US20020058623 Addition of cysteine delays the temporal decrease in the effective concentration of the protein. The process is suitable for use in the production of heterologous proteins in microorganisms. |
05/16/2002 | US20020058324 Protein recovery |
05/16/2002 | US20020058303 Enhanced in vitro synthesis of active proteins containing disulfide bonds |